Related Experiment Video
Updated: Oct 26, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Prenatal caffeine exposure: association with neurodevelopmental outcomes in 9- to 11-year-old children
Rui Zhang1, Peter Manza1, Nora D Volkow1,2
1Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Insights
Prenatal caffeine exposure, even at recommended doses, is linked to increased behavioral issues and altered brain structure in children. Further research is needed to determine if the "safe" caffeine limit during pregnancy requires adjustment.
Area of Science:
- Neuroscience
- Developmental Psychology
- Public Health
Background:
- Caffeine is widely consumed, including during pregnancy.
- The impact of prenatal caffeine exposure on child development remains unclear.
Purpose of the Study:
- To investigate the association between prenatal caffeine exposure and child developmental outcomes.
- To explore dose-dependent effects of caffeine exposure on behavior and brain structure.
Main Methods:
- Utilized data from the Adolescent Brain and Cognitive Development Study (n=11,875 children aged 9-11).
- Analyzed associations between prenatal caffeine exposure levels and various child outcomes.
- Included birth outcomes, physical health, behavior, cognition, substance use, and brain structure.
Main Results:
- Prenatal caffeine exposure, including recommended doses, correlated with increased externalizing behavior problems.
- Higher caffeine intake was linked to greater BMI and soda consumption.
- Observed brain structural changes included altered cortical thickness and sulcal depth.
- Effect sizes for externalizing problems were comparable to those of prenatal alcohol and cannabis exposure.
Conclusions:
- The "safe" caffeine dose during pregnancy warrants further investigation for clinical relevance and potential adjustment.
- Prenatal caffeine use should be considered as a covariate in studies of prenatal drug exposure due to its high prevalence.
Background:
Despite the widespread use of caffeine including consumption during pregnancy, the effect of prenatal caffeine exposure on child brain development and behavior is unclear.
Methods:
To address this, we used data from the Adolescent Brain and Cognitive Development Study (n = 11,875 children aged 9-11 years from 22 sites across the United States). We explored the associations between prenatal caffeine exposure and various developmental outcomes including birth outcomes, physical health, behavior problems, cognition, substance use and brain structure in children, and evaluated dose effects.
Results:
Among 9,978 children (4,745 females) who had valid data for prenatal caffeine exposure and whose mothers did not use drugs of abuse after knowing of pregnancy, 4,170 (41.79%) had no prenatal caffeine exposure, 2,292 (22.97%) had daily, 1,933 (19.37%) had weekly, and 1,583 (15.86%) had less than weekly exposures. Prenatal caffeine exposure including the widely recommended 'safe' dose was associated with greater externalizing problems, whereas greater BMI and soda consumption were only observed in children with high dose exposures (3+ per day). Notably, the effect size for association of externalizing problems with prenatal caffeine exposure was comparable with that reported for prenatal alcohol (The American Journal of Psychiatry, 177, 2020 and 1060) and prenatal cannabis (JAMA Psychiatry, 78, 2020 and 64) exposures from previous ABCD publications. Additionally, prenatal caffeine exposure was associated with brain structural changes that included greater posterior and lower frontal cortical thickness and altered parietooccipital sulcal depth.
Conclusions:
The recommended 'safe' dose of caffeine during pregnancy should be carefully studied to assess whether the behavioral and brain correlates observed here are clinically relevant and determine whether it needs adjustment. Because of the high prevalence of caffeine use in the general population, studies on prenatal exposure to drugs of abuse should include prenatal caffeine use as a covariate.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Teratogenicity
Information Processing Approach

